A carregar...

Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival

BACKGROUND: KRAS mutations reported in non-small cell lung cancer (NSCLC) represent a significant percentage of patients diagnosed with NSCLC. However, there still remains no therapeutic option designed to target KRAS. In an era with immunotherapy as a dominant treatment option in metastatic NSCLC,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Amanam, Idoroenyi, Mambetsariev, Isa, Gupta, Rohan, Achuthan, Srisairam, Wang, Yingyu, Pharaon, Rebecca, Massarelli, Erminia, Koczywas, Marianna, Reckamp, Karen, Salgia, Ravi
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7578487/
https://ncbi.nlm.nih.gov/pubmed/33145085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.04.18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!